Miconazole mucoadhesive tablets

A novel delivery system

Jose Antonio Vazquez, Jack D. Sobel

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Oropharyngeal candidiasis (OPC) is among the most common opportunistic infections observed in persons infected with human immunodeficiency virus. A once-daily miconazole 50 mg mucoadhesive buccal tablet (MBT) is a novel delivery system with potent in vitro activity against many Candida species, including some that may be resistant to other azoles. MBT, although more expensive, offers an effective, safe, and well-tolerated topical treatment option for OPC that is administered as a convenient once-daily dose.

Original languageEnglish (US)
Pages (from-to)1480-1484
Number of pages5
JournalClinical Infectious Diseases
Volume54
Issue number10
DOIs
StatePublished - May 15 2012
Externally publishedYes

Fingerprint

Miconazole
Cheek
Candidiasis
Tablets
Azoles
Opportunistic Infections
Candida
HIV
In Vitro Techniques

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Miconazole mucoadhesive tablets : A novel delivery system. / Vazquez, Jose Antonio; Sobel, Jack D.

In: Clinical Infectious Diseases, Vol. 54, No. 10, 15.05.2012, p. 1480-1484.

Research output: Contribution to journalReview article

@article{1adea2fca33b47fdb35cdf91480b622a,
title = "Miconazole mucoadhesive tablets: A novel delivery system",
abstract = "Oropharyngeal candidiasis (OPC) is among the most common opportunistic infections observed in persons infected with human immunodeficiency virus. A once-daily miconazole 50 mg mucoadhesive buccal tablet (MBT) is a novel delivery system with potent in vitro activity against many Candida species, including some that may be resistant to other azoles. MBT, although more expensive, offers an effective, safe, and well-tolerated topical treatment option for OPC that is administered as a convenient once-daily dose.",
author = "Vazquez, {Jose Antonio} and Sobel, {Jack D.}",
year = "2012",
month = "5",
day = "15",
doi = "10.1093/cid/cis205",
language = "English (US)",
volume = "54",
pages = "1480--1484",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Miconazole mucoadhesive tablets

T2 - A novel delivery system

AU - Vazquez, Jose Antonio

AU - Sobel, Jack D.

PY - 2012/5/15

Y1 - 2012/5/15

N2 - Oropharyngeal candidiasis (OPC) is among the most common opportunistic infections observed in persons infected with human immunodeficiency virus. A once-daily miconazole 50 mg mucoadhesive buccal tablet (MBT) is a novel delivery system with potent in vitro activity against many Candida species, including some that may be resistant to other azoles. MBT, although more expensive, offers an effective, safe, and well-tolerated topical treatment option for OPC that is administered as a convenient once-daily dose.

AB - Oropharyngeal candidiasis (OPC) is among the most common opportunistic infections observed in persons infected with human immunodeficiency virus. A once-daily miconazole 50 mg mucoadhesive buccal tablet (MBT) is a novel delivery system with potent in vitro activity against many Candida species, including some that may be resistant to other azoles. MBT, although more expensive, offers an effective, safe, and well-tolerated topical treatment option for OPC that is administered as a convenient once-daily dose.

UR - http://www.scopus.com/inward/record.url?scp=84860251686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860251686&partnerID=8YFLogxK

U2 - 10.1093/cid/cis205

DO - 10.1093/cid/cis205

M3 - Review article

VL - 54

SP - 1480

EP - 1484

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 10

ER -